Sarah Cannon Cancer Network | LinkedIn (original) (raw)

Hospitals and Health Care

Nashville, TN 9,681 followers

A globally recognized network of oncology specialists providing cutting-edge cancer treatment close to home.

View all 413 employees

About us

The HCA Healthcare Sarah Cannon Cancer Network offers integrated cancer services with convenient access to cutting-edge therapies for those facing cancer in communities across the United States and United Kingdom. Sarah Cannon’s cancer programs include individualized patient navigation provided by oncology-trained nurses, more than 1,200 stem cell transplants performed annually throughout the Sarah Cannon Blood Cancer Network, hundreds of clinical trials, and molecular profiling capabilities. Through its services, Sarah Cannon is providing state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.

Industry

Hospitals and Health Care

Company size

501-1,000 employees

Headquarters

Nashville, TN

Type

Public Company

Specialties

Oncology, Cancer Research, Cancer Care, and Clinical Trials

Locations

Employees at Sarah Cannon Cancer Network

Updates

9,681 followers
3mo Edited
We can change cancer care together. Learn more about HCA Healthcare Sarah Cannon Cancer Network: https://bit.ly/4aZ5cMh
HCA Healthcare Sarah Cannon Cancer Network

https://www.youtube.com/

This weekend, we’re joining oncology professionals worldwide as we gather for the American Society of Clinical Oncology (ASCO) Annual Meeting, where we’ll be making connections and forging collaborations to change the landscape of cancer care. Additionally, this #ASCO2024we are proudly introducing the new HCA Healthcare Sarah Cannon Cancer Network brand. Stop by our booth to learn more about the many ways we’re moving cancer care forward.
Sarah Cannon Cancer Network reposted this

Senior Vice President Sarah Cannon Cancer Network Nashville, TN
4mo
Many of you are aware that Dr. Fred LeMaistre recently announced his impending retirement. Fred’s career is replete with contributions to science, to the healthcare industry, and to patients across the world. I am deeply grateful for his contributions to and leadership of the HCA Healthcare Sarah Cannon Cancer Network. It has been a privilege to work alongside Fred these past seven years. In that context, I am thrilled to share that I have accepted the role of Senior Vice President, HCA Healthcare Sarah Cannon Cancer Network. I am honored to work alongside a team of talented clinical and administrative leaders who share the common goal of bringing the most sophisticated and evidence-based cancer care to patients in the communities in which they live. No one with cancer should need to “know” someone in the business to be confident they are receiving great cancer care nor should they have to sacrifice the benefits of being close to home to receive that care. The HCA Healthcare Sarah Cannon Cancer Network represents a comprehensive, national network of cancer professionals working in tandem in the pursuit of high quality, innovative, research-backed cancer care close to home. Our focus is more clear than ever – empower our patients through personalized, multidisciplinary treatment plans and nationally recognized navigation services; empower our providers through the provision of state of the art surgical, radiation, and medical oncology technologies; and drive our field forward by our unwavering commitment to clincial trials as a first, not last, choice. We will build on our existing partnerships and forge new ones as we relentlessly pursue our commitment to the improvement of human life.Sarah Cannon Cancer Network HCA Healthcare Sarah Cannon Research Institute #ASCO24 #Oncology #CancerCare
#Tandem24 is wrapping up today. What an incredible learning and networking opportunity this has been. For those attending the conference, we hope you have been able to visit the Sarah Cannon Cancer Institute booth #501 to learn about the incredible work our clinicians are doing every day as well as career opportunities available with the Sarah Cannon Cancer Institute. Let us introduce two more nursing colleagues who round out our spotlights. Colin Chow, ARNP, Mountain View Hospital: Colin knew at an early age that he had a strong desire to positively impact people’s lives. He found his niche working as an oncology nurse five years ago. During that time Colin became one of the nurses for Nevada’s first stem cell transplant program and knew he had more growth to do from there. Colin became a nurse practitioner specializing in stem cell transplant. He now practices at Mountain View Hospital in Nevada. Colin says he is “so proud to be part of the Sarah Cannon family not only for their commitment to the care and improvement of human life, centers of excellence, or global expertise, but because they uphold the true meaning of ‘family.’ The individuals who I have worked with from the organization or have come in contact with have been incredibly helpful and welcoming.” Angela Maxwell, RN, Medical City Dallas: In her 22 years as a registered nurse, Angela has cared for others in many different roles. Her journey in oncology nursing began in 2017 at the Bone Marrow Transplant unit of Medical City Dallas. Since then, she transitioned to transplant coordinator and most recently, to the PI and quality coordinator role. Angela says by working on the floor before taking on other roles she learned what the transplant process looks like from admission to recovery. Her ability to see the big picture helps her provide quality care and make changes that will keep the Blood and Marrow Transplant Program going strong. “I am proud to be a part of the Sarah Cannon family because we are part of a network that genuinely cares about the patients, not just the metrics. Each hospital within the network can rely on each other for support, evidence-based research and guidance, and the benefit of experience within our programs. We are stronger together,” Angela said. Thank you, Colin and Angela, for being an incredible example of how we care like family. To learn more about our career opportunities, please visit our careers page: https://bit.ly/3UNOavOEnjoy the final sessions of #Tandem24! Thank you ASTCT and Center for International Blood & Marrow Transplant Research (CIBMTR)! We are already looking forward to next year!
The first couple of days of #Tandem24 have already been inspiring, informative, and transformational. The next two days will offer additional opportunities to learn about the innovative strides being made in blood cancer research and treatment. Katie Bruce, clinical pharmacy specialist, will present on “High-Risk Neuroblastoma” in the pediatric population at 9:30 a.m. Central Time today. Tomorrow, Stephanie M Larson, senior director of transplant & cellular therapy clinical programs, will present at 9:30 a.m Central Time on “Interactive Education: One Way to Measure Success” as well as on “Building the Infrastructure for Gene Therapy in 2024” at 3:15 p.m. Central Time.
Sarah Cannon Cancer Network reposted this
Today, we are proud to announce that HCA Healthcare’s Sarah Cannon Cancer Institute (SCCI) has successfully established an integrated management process that safely transitioned more than 75% of HCA Healthcare’s CAR T-cell therapy patients into an outpatient setting for monitoring. The program model resulted in more than 1,200 hospital bed days saved for the first 100 patients of the program compared to historical results, and approximately 20% of patients avoided hospitalization altogether. Piloted at four Sarah Cannon Transplant and Cellular Therapy Network (SCTCTN) sites and using new technology for at-home patient monitoring, trained outpatient clinical teams, including nurses, clinical pharmacists, advanced practice professionals, social workers and case managers, have created a model to help reduce the time patients spend in the hospital after treatment during the typical two-week monitoring period. “Patients heal better outside the hospital if they can get these complicated therapies, which carry risk for significant complications, safely in the outpatient setting,” said Dr. Navneet Majhail, physician-in-chief of blood cancers, Sarah Cannon Transplant & Cellular Therapy Network. “We have leveraged technology and developed clinical pathways to care for patients receiving CAR T-cell therapies. Our clinical teams have accomplished this by standardizing care across a network of several cell therapy programs.” Best Buy Health’s remote patient monitoring platform, Current Health, tailored for CAR T-cell therapy patients, collects continuous vital sign data and monitors symptoms through integrated wearable devices. Learn more about the initiative to safely transition a substantial portion of CAR T-cell therapy monitoring into patients’ homes: https://bit.ly/3OVhoVX.#ImproveMoreLives
HCA Healthcare's Sarah Cannon Cancer Institute implements new outpatient model for CAR T-cell therapy https://hcahealthcaretoday.com
We are proud to highlight Misty Evans, pediatric nurse practitioner at the Sarah Cannon Transplant and Cellular Program at TriStar Centennial Medical Center, for being recognized by the ASTCT as the 2024 Advanced Practice Provider (APP) Special Interest Group (SIG) Lifetime Achievement Award recipient at #Tandem24. “I cannot think of anyone more deserving for the Lifetime Achievement Award,” shared Dr. Haydhar Frangoul, medical director of pediatric hematology/oncology for the Sarah Cannon Pediatric Transplant and Cellular Therapy Program at TriStar Centennial Medical Center. “She has been a leader at the local and national level. She is compassionate, caring and provides outstanding patient care.” This award recognizes a Special Interest Group member for their outstanding work and dedication to APP practice in hematopoietic cell transplantation (HCT) and cellular therapy. Dr. Evans previously served as the chair of the Advanced Practice Provider Special Interest Group of the American Society for Transplantation and Cellular Therapy (ASTCT) and has remained dedicated to providing exceptional contributions to the field through presentations, mentorship, and leadership. Thank you, Dr. Evans, for all you do to impact patient lives and the field of transplantation and cellular therapy nursing practice. Congratulations on your achievements!
9,681 followers
7mo Edited
We hope all #Tandem24 attendees have been enjoying this week’s conference as much as we have! We invite you to join us this afternoon as Dr. Haydhar Frangoul, medical director of pediatric hematology/oncology for Sarah Cannon Research Institute and HCA Healthcare’s Children's Hospital at TriStar Centennial Medical Center, participates in the “Sickle Cell Disease: Haplo Versus Gene Therapy Debate.” The discussion begins at 1:45 p.m. Central Time with Dr. Frangoul taking the stage at 2:08 p.m.

Join now to see what you are missing

Join now

Sarah Cannon Cancer Network | LinkedIn (original) (raw)

Hospitals and Health Care

Nashville, TN 9,681 followers

A globally recognized network of oncology specialists providing cutting-edge cancer treatment close to home.

About us

Locations

Employees at Sarah Cannon Cancer Network

Updates

https://www.youtube.com/

Join now to see what you are missing

Affiliated pages

Similar pages

Browse jobs